๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Royalty Pharma plc (RPRX)
NASDAQ: RPRX ยท Real-Time Price ยท USD
68.45
+0.73 (1.08%)
At close: Nov 20, 2026, 4:00 PM EST
67.65
-0.80 (-1.17%)
After-hours: Nov 20, 2026, 7:48 PM EST

Royalty Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,6172,3782,2642,3552,2372,289
Revenue Growth
11.36%5.06%-3.86%5.24%-2.28%7.87%
Gross Profit
2,6112,6741,5311,7941,3331,837
Operating Income
1,6861,5601,2921,492922.891,431
Net Income
672.45770.95858.981,13542.83619.73
Earnings Per Share
1.531.781.912.530.101.49
EPS Growth
-12.48%-6.83%-24.54%2490.74%-93.44%12.97%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cystic Fibrosis Franchise
853.84828.18826.21852.31808.95762.89
Tremfya
231.04152.94147.14149.72109.816.71
Evrysdi
225.62206.97224.4397.74--
Voranigo
177.7154.4246.15---
Trelegy
160.2154.1146.92128.0557.93-
Tysabri
112.67116.88124.82167.54207.16211.42
Other Products
711.99647.67633.76629.24630.33507.52
Other Royalty Income and
143.75117.04114.15156.8112.12224.38
Revenue (Total)
2,6172,3782,2642,3552,2372,289

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
544.86637.5987.23495.311,7362,189
Total Debt
8,5878,9707,6126,1357,1167,096
Net Cash (Debt)
-8,043-8,333-6,625-5,640-5,380-4,907
Net Cash Growth
------
Net Cash Per Share
-16.90-14.76-11.15-9.35-12.28-11.83

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
2,9602,4902,7692,9882,1442,018
Free Cash Flow
2,9602,4902,7692,9882,1442,018
Free Cash Flow Growth
23.06%-10.08%-7.32%39.36%6.27%-0.84%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
99.79%112.44%67.64%76.19%59.58%80.22%
Operating Margin
64.41%65.58%57.10%63.37%41.25%62.49%
Pretax Margin
44.84%55.68%58.79%72.20%10.28%54.21%
Profit Margin
25.70%32.42%37.95%48.20%1.92%27.07%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.9400.8800.8400.8000.7600.680
Dividend Per Share Growth
6.82%4.76%5.00%5.26%11.77%126.67%
Dividend Yield
1.37%2.28%3.31%2.86%1.93%1.72%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
44.7021.4113.2011.01407.0027.62
Forward PE
10.497.706.107.4710.3213.00
PS Ratio
15.006.945.015.317.797.48